EUVIMEDEUVIMED entdecken
Crossref

Health, Patents, and Path Dependence: India's Pharmaceutical Crossroads

Jacie Bissell

Michigan Technology Law Review · 01.07.2026 · 337

DOI: 10.36645/mtlr.32.2.health ↗

Kurz gefasst

Fachartikel in der Zeitschrift Michigan Technology Law Review, online erschienen am 01.07.2026. Verfasst von Jacie Bissell.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper examines how India’s historical commitment to affordable medicine and public health continues to shape its pharmaceutical patent regime, even as the country aspires to become an innovation-driven economy. Through the lens of path dependence, the paper explores how India’s legal and institutional frameworks have created structural constraints on policy reform. Focusing on key moments such as the Patents Act of 1970, the landmark Novartis decision, and India’s evolving stance on the TRIPS waiver during the COVID-19 pandemic, the paper analyzes the tensions between fostering pharmaceutical innovation and maintaining access to affordable medicines. While recent procedural reforms and judicial decisions signal a shift toward encouraging investment and R&D, the enduring influence of India’s generics-oriented legacy raises questions about the feasibility of this transition. Understanding this dynamic is essential to evaluating India’s future role in global pharmaceutical innovation and access.

Zitieren

APA

Bissell, J. (2026). Health, Patents, and Path Dependence: India's Pharmaceutical Crossroads. Michigan Technology Law Review, 337. https://doi.org/10.36645/mtlr.32.2.health

Vancouver

Bissell J. Health, Patents, and Path Dependence: India's Pharmaceutical Crossroads. Michigan Technology Law Review. 2026:337. doi:10.36645/mtlr.32.2.health

BibTeX
@article{Bissell2026,
  author = {Bissell, Jacie},
  title = {Health, Patents, and Path Dependence: India's Pharmaceutical Crossroads},
  journal = {Michigan Technology Law Review},
  year = {2026},
  pages = {337},
  doi = {10.36645/mtlr.32.2.health}
}
Kostenlos starten →